Even though a recently released defense-strategy report scarcely mentions Russia, don’t expect the Pentagon to brush it aside anytime soon.
A “wholesale redo” of the review, which broadly outlines the Defense Department’s strategy every four years, isn’t necessary — despite the crisis in Ukraine, Christine Wormuth, deputy undersecretary of defense for strategy, plans, and force development, said Monday.
The 64-page document, which came out March 4, made little mention of Russia, dedicating just one paragraph to outlining the possible risks it may pose to Washington’s or its allies’ interests.
The document did note that some of Russia’s military actions could “violate the sovereignty of its neighbors” and “present risks,” adding that the United States will try to work with Russia to “reduce the risk of military miscalculation.”
But the Pentagon’s review is “kind of broadly envisioned and would allow us to kind of do the kinds of things that we need to do to both support the government of Ukraine and reassure our NATO allies,” Wormuth said.
But if the Defense Department wants to be able to tackle a swath of issues outlined in the defense review — ranging from containing Russian influence or shifting the U.S. focus to the Asia-Pacific region — it will need Congress to cough up the extra $115 billion over five years the administration has requested in its five-year budget plan, Wormuth said.
“This is not a post-Cold War, early-90s kind of security environment,” said Wormuth, who is also the president’s nominee to become the department’s undersecretary for policy. “You can’t live in a mansion if you’re working on a middle-class salary. At a certain point we are going to have to ask ourselves, ‘What kind of nation do we want to be?’ “
What We're Following See More »
"A federal district court in Hawaii has temporarily blocked the third iteration of President Trump's travel ban. Judge Derrick Watson said the new targeted restrictions on travel from eight countries Trump issued on Sept. 24 suffers the same problems as the previous order."
"President Donald Trump is leaning toward nominating Alex Azar, a former pharmaceutical industry executive and George W. Bush administration official, to serve as Health and Human Services secretary, according to two White House officials...Azar is a veteran of HHS. He served as the department’s general counsel and deputy secretary during the Bush administration." He led Eli Lilly's U.S. operations from 2012-17.
"Sen. Lamar Alexander says he and Sen. Patty Murray have reached a deal to fund the Affordable Care Act's cost-sharing subsidies in exchange for giving states more regulatory flexibility with the law." Axios is watching to see if the deal will gather support.